Articles On Avita Medical (ASX:AVH)

In afternoon trade the S&P/ASX 200 index is on course to finish the week on a positive note:. At the time of writing the benchmark index is up 0.3% to 7,031.1 points. Four shares that have climbed more than most today are listed below....

The AVITA Medical Ltd (ASX: AVH) share price has been a strong performer on Friday. In afternoon trade the global regenerative medicine company’s shares are up 6.5% to 68.2 cents. This makes AVITA the second-best performer on the ASX 200 i...

A choppy week looked set to end with an uplift as the share market recouped yesterday’s losses following a late reversal on Wall Street. The ASX 200 bounced 17 points or 0.2 per cent to 7025 this morning, but remained on track for its fi...

The GUD Holdings Limited (ASX: GUD) share price is on course to end the week on a positive note. In afternoon trade the diversified products company’s shares are up 6% to $11.87. This makes it the third-best performer on the ASX 200 index...

The Australian market lost yesterday’s gains as the number of reported coronavirus cases nears 8000 and impacts Asian markets. Despite morning gains, the ASX 200 trailed off just over an hour into the session. The benchmark index relin...

AVITA Medical (ASX:AVH) has announced that the US FDA has approved its application to conduct a feasibility study evaluating the safety and effectiveness of the RECELL Autologous Cell Harvesting Device for repigmentation of depigmen...

Investment site MarketIndex regularly aggregates the ratings of analysts from different brokerages to provide a market consensus on ASX shares. This consensus can be used to uncover ASX shares that warrant further investigation. Here are...

The PolyNovo Ltd (ASX: PNV) share price closed yesterday’s trading session more than 8% higher. Although there was no direct catalyst to prompt the share price move, it could be an indication of continued interest in the company. What does...

In 2019 the culmination of decades worth of work turned several biotechs and life sciences companies into overnight successes. As investors look to defensive growth stocks to compensate for a sluggish economy and with expectations of more h...

It was a great year for ASX healthcare shares in 2019, with the S&P/ASX Healthcare Index increasing by 41%. These 3 ASX healthcare shares experienced even greater gains in 2019, but can they continue to outperform in 2020?  Avita Med...

In 2019, the S&P/ASX 200 (INDEXASX: XJO) increased nearly 22%. Avita Medical Ltd (ASX: AVH) was the star performer on the index, up more than 700% for the year. Polynovo Ltd (ASX: PNV), EML Payments Ltd (ASX: EML), and Fortescue Metals...

The S&P/ASX 200 index was in fine form in 2019, ending the year with a return of just over 20% excluding dividends. Whilst the majority of shares on the index raced higher, a number climbed more than most. Here’s why these were the bes...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Monday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.25% to 6...

Avita Medical (AVH) has received FDA approval to conduct a feasibility study evaluating its Recell device Recell is used to deliver pigment to lesions affected by vitiligo Vitiligo is a disease resulting in the loss of pigmentation in pa...

30 Dec 2019 - AVITA Medical (ASX:AVH, NASDAQ:RECEL) has announced the resignation of joint company secretary Tamara Barr and secured US FDA approval to conduct a feasibility study …

The AVITA Medical Ltd (ASX: AVH) share price will be on watch on Monday after the release of a positive announcement. What did AVITA announce? This morning AVITA announced that the U.S. Food and Drug Administration (FDA) has approved the c...

The year is nearly over, so I think it’s time to look back at some of the shares that could be called shares of the year. A special shout-out must go to Avita Medical Ltd (ASX: AVH) and Opthea Ltd (ASX: OPT) as two of the best performers o...

At every investor presentation – and he’s fronted a few – Avita Medical (ASX:AVH) chief executive Dr Mike Perry includes a before-and-after picture of the visage of a 12-year-old girl who suffered burns to two-thirds of her body when her fa...

Why do investors consider having diversified stocks? The most crucial principle of investing is to have a variety of stocks in the portfolio. This would imply the investors investing their money in different types of stocks, so that they ar...

The stock markets are sensitive to the macro-economic environment as well as to the health of global economy. If global growth comes into question, the stock markets might witness unfavourable impacts. Let us now have a look at performance...

The S&P/ASX 200 index closed lower, down by 18.3 points or 0.27 per cent at 6,833.1 points relative to the last close. And, the All Ordinaries index closed lower by 0.21 per cent or 14.4 points to close at 6,942.6 points. Some of the b...

Being the most dynamic industry, in the health care sector, there is always a need for innovation to develop new therapies, medical devices as well as diagnostic solutions for patients. Medical device and pharma & biotech companies are...

At lunch on Wednesday the S&P/ASX 200 index is struggling once again. At the time of writing the benchmark index is slightly lower at 6,843.4 points. Here’s what has been happening on the market today: NAB tumbles. The National Austral...

Earlier today I looked at three ASX 200 shares that have been smashed in 2019. Thankfully, these shares are in the minority, with the majority of shares on the index recording solid gains this year. Three ASX 200 shares that are leading th...

With the year coming to a close, I thought it would be interesting to look at 2019 in terms of some of the movements we saw in the ASX300 and its constituents. While there are still 2 weeks to go, we enter 2020 vastly different to how we st...

The Opthea Ltd (ASX: OPT) share price has been one of the best performers on the All Ordinaries in 2019. Since the start of the year the shares of the developer of novel biologic therapies for the treatment of eye diseases have gained a ma...

The S&P/ASX 200 index closed lower, down 23.1 points or 0.34 per cent at 6,706.9 points relative to the last close. The All Ordinaries index was lower by 0.36 per cent or 24.3 points to close at 6,812.1 points. Some of the best & w...

At lunch on Tuesday the S&P/ASX 200 index is trading ever so slightly higher. The benchmark index is up a few points to 6,732.5 points at the time of writing. Here’s what has been happening on the market today: Bank shares lower.   The...

The introduction of innovative technologies in the health care sector has entirely transformed the industry and has appeared as a boon for patients, clinicians, researchers and scientists.  Health care expenditure is increasing at the globa...

The S&P/ASX 200 index closed higher, ending 23 points or 0.34 per cent higher at 6,730 points relative to the last close. The All Ordinaries index was higher by 0.33 per cent or 22.9 points to close at 6,836.4 points. Some of the best...

Capital growth occurs when share prices to increase in value, and in 2019 we have seen some shares soar to new heights. Here we take a look at 3 ASX shares that have tripled in value (or more) in 2019. WISR Ltd (ASX: WZR) Currently trading...

Carrie LaFrenz published an article in the Australian Financial Review discussing how Avita Medical’s spray-on skin product is revolutionising care for burn patients. Carrie draws on Joseph’s comment that they are right on path with the rei...

If you’re anything like me, you’re probably looking to invest better in 2020. While 2019 has been a bumper year for the S&P/ASX 200 (INDEXASX: XJO), I’m always looking to improve my returns. The good news is, by considering the tax imp...

Australian equities are very sensitive to the performance of global economy as well as to the health of Australian economy. A rise in economic uncertainties might weigh over the sentiments of the market players and they might decide to make...

Health care system in Australia ranks well internationally with the presence of big pharmaceutical companies. With the push created by improvements in medical technology, such as advances in diagnostic and therapeutic-new radiological scann...

The S&P/ASX 200 index closed higher, ending 24 points or 0.36 per cent higher at 6,707 points relative to the last close. And, the All Ordinaries index higher by 0.33 per cent or 22.4 points to close at 6,813.5 points. Some of the best...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Friday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.36% to...

Sometimes value is visible in plain sight. Avita Medical’s (ASX: AVH) RECELL technology solution for burns patients represents the commercialisation of the invention of West Australian Fiona Wood. Instead of harvesting large amounts of skin...

The S&P/ASX 200 index closed lower, ending 105.8 points or 1.6 per cent lower at 6,606.5 points relative to the last close. And, the All Ordinaries index dropped by 1.55 per cent or 104 points to close at 6,714.4 points. The new vehicl...

The S&P/ASX 200 Index (INDEXASX: XJO) came crashing back to earth on Tuesday as it plummeted 2.19% lower. The ASX 200 closed at 6,712.30 points while the All Ordinaries Index (INDEXASX: XAO) dipped 2.11% to 6,818.40 points. That’s the...

The S&P/ASX 200 index closed lower, ending 150 points/ 2.23% lower at 6712.3 points relative to the last close. All Ordinaries index was down by 2.15%/ 146.9 points to close at 6,818.4 points.  Some of the best & worst performing s...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Tuesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 2.21% to ...

In afternoon trade the S&P/ASX 200 index is a sea of red. At the time of writing the benchmark index is down 2% to 6,721.8 points. Four shares that are falling more than most today are listed below. Here’s why they are sinking lower: T...

At lunch on Tuesday the S&P/ASX 200 index is on course to record a very disappointing decline. At the time of writing the benchmark index is down 1.7% to 6,743.8 points. Here’s what has been happening on the market today: ASX 200 notab...

On 2 December 2019, the S&P/ASX 200 Health Care Sector (XHJ) traded higher at 42,106.3 points, with a rise of 0.83% compared to the last close. The S&P/ASX 200 Index traded at 6,862.3 points, up by 0.24% from its previous close. YT...

Australian health care is a lucrative sector with strong growth prospects. Amid global worries, the health care sector gained tremendous attention from the investors in having the potential to generate huge profit in short span of time. In...

The best performer on the ASX 200 index this year has been the AVITA Medical Ltd (ASX: AVH) share price. Since the start of the year the global regenerative medicine company’s shares have gained a remarkable 686%. The next best performers...

The Australian Medicare is the foundation of the health care system since 1984 and has three major divisions- public hospitals, medical services and medicines. One of the essential parts of Medicare is the Pharmaceutical Benefits Scheme (PB...

In the Australian health care sector, the advancement in medical science have completely changed the health care services. New and advanced technologies have a high impact on medical and health services. These technologies are improving the...

AVITA Medical (ASX:AVH) and scientists at the Gates Center for Regenerative Medicine at the University of Colorado School of Medicine have announced a preclinical research collaboration.